Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 833

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 833
---
--|:--|-------:|:--|:--|
| Balance, December 31, 2020                                      | ​ | ​ | ​                                                 | $ |     73 | ​ | ​ |
| Other comprehensive loss before reclassifications               | ​ | ​ | ​                                                 | ​ |   -392 | ​ | ​ |
| Amount reclassified from accumulated other comprehensive income | ​ | ​ | ​                                                 | ​ |    -39 | ​ | ​ |
| Net current period other comprehensive loss                     | ​ | ​ | ​                                                 | ​ |   -431 | ​ | ​ |
| Balance, December 31, 2021                                      | ​ | ​ | ​                                                 | ​ |   -358 | ​ | ​ |
| Other comprehensive loss before reclassifications               | ​ | ​ | ​                                                 | ​ | -1,314 | ​ | ​ |
| Amount reclassified from accumulated other comprehensive loss   | ​ | ​ | ​                                                 | ​ |      — | ​ | ​ |
| Net current period other comprehensive loss                     | ​ | ​ | ​                                                 | ​ | -1,314 | ​ | ​ |
| Balance, December 31, 2022                                      | ​ | ​ | ​                                                 | $ | -1,672 | ​ | ​ |
| Other comprehensive income before reclassifications             | ​ | ​ | ​                                                 | ​ |  1,412 | ​ | ​ |
| Amount reclassified from accumulated other comprehensive loss   | ​ | ​ | ​                                                 | ​ |      — | ​ | ​ |
| Net current period other comprehensive income                   | ​ | ​ | ​                                                 | ​ |  1,412 | ​ | ​ |
| Balance, December 31, 2023                                      | ​ | ​ | ​                                                 | $ |   -260 | ​ | ​ |

F-57

TABLE OF CONTENTS

CARA THERAPEUTICS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(amounts in thousands, except share and per share data) Amounts reclassified out of accumulated other comprehensive (loss) income into net loss are determined by specific identification. The reclassifications out of accumulated other comprehensive (loss) income and into net loss were as follows:

| ​                                                             
 ​                                                             
 Component of Accumulated Other Comprehensive Income (Loss)    | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | ​                       
 Year Ended December 31, 
 2023                    | ​ | ​ | ​